| MR编号 | CZ/H/0233/005 |
|---|
| 药品名称 | VALSACOMBI 320 MG/25 MG |
|---|
| 活性成分 | - Hydrochlorothiazide 25.0 mg
- Valsartan 320.0 mg
|
|---|
| 剂型 | Film-coated tablet |
|---|
| 上市许可持有人 | Krka d.d., Novo mesto
Šmarješka cesta 6
8501 Novo mesto
Slovenia |
|---|
| 参考成员国 - 产品名称 | Czechia (CZ) sukls149990/2013 |
|---|
| 互认成员国 - 产品名称 | - Germany (DE)
Valsartan/Hydrochlorothiazid TAD 320 mg/25 mg Filmtabletten - Denmark (DK)
- Ireland (IE)
- Austria (AT)
Valsartan/Hydrochlorothiazid Krka 320 mg/25 mg Filmtabletten - Spain (ES)
- Greece (GR)
- Sweden (SE)
Valsartan/Hydrochlorothiazide Krka - Norway (NO)
- Finland (FI)
- Poland (PL)
Co-Valsacor - Latvia (LV)
- Lithuania (LT)
Valsacombi 320 mg/25 mg plėvele dengtos tabletės - Estonia (EE)
VALSACOMBI - Hungary (HU)
CO-VALSACOR 320 mg/25 mg filmtabletta - Bulgaria (BG)
Co-Valsacor - Slovakia (SK)
Co-Valsacor 320 mg/25 mg filmom obalené tablety - Slovenia (SI)
|
|---|
| 许可日期 | 2010/11/15 |
|---|
| 最近更新日期 | 2025/05/21 |
|---|
| 药物ATC编码 | - C09DA03 valsartan and diuretics
| 申请类型 | - TypeLevel1：Abridged
- TypeLevel2：Initial Application
- TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|